Burkhardt O - Search Results

1

Procalcitonin guidance and reduction of antibiotic use in acute respiratory tract infection.

Burkhardt O, Ewig S, Haagen U, Giersdorf S, Hartmann O, Wegscheider K, Hummers-Pradier E, Welte T. Burkhardt O, et al. Eur Respir J. 2010 Sep;36(3):601-7. doi: 10.1183/09031936.00163309. Epub 2010 Feb 25. Eur Respir J. 2010. PMID: 20185423 Free article. Clinical Trial.

2

Nosocomial methicillin-resistant Staphylococcus aureus (MRSA) pneumonia: linezolid or vancomycin? - Comparison of pharmacology and clinical efficacy.

Pletz MW, Burkhardt O, Welte T. Pletz MW, et al. Among authors: burkhardt o. Eur J Med Res. 2010 Nov 30;15(12):507-13. doi: 10.1186/2047-783x-15-12-507. Eur J Med Res. 2010. PMID: 21163725 Free PMC article. Review.

3

10 years' experience with the pneumococcal quinolone moxifloxacin.

Burkhardt O, Welte T. Burkhardt O, et al. Expert Rev Anti Infect Ther. 2009 Aug;7(6):645-68. doi: 10.1586/eri.09.46. Expert Rev Anti Infect Ther. 2009. PMID: 19681692 Review.

4

Pulmonary infiltrates in Costello Syndrome.

Waldburg N, Buehling F, Evert M, Burkhardt O, Welte T. Waldburg N, et al. Among authors: burkhardt o. Eur Respir J. 2004 May;23(5):783-5. doi: 10.1183/09031936.04.00073704. Eur Respir J. 2004. PMID: 15176697 Free article.

5

Once-daily tobramycin in cystic fibrosis: better for clinical outcome than thrice-daily tobramycin but more resistance development?

Burkhardt O, Lehmann C, Madabushi R, Kumar V, Derendorf H, Welte T. Burkhardt O, et al. J Antimicrob Chemother. 2006 Oct;58(4):822-9. doi: 10.1093/jac/dkl328. Epub 2006 Aug 2. J Antimicrob Chemother. 2006. PMID: 16885180 Clinical Trial.

6

Prognostic value of procalcitonin in respiratory tract infections across clinical settings.

Kutz A, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Schuetz P. Kutz A, et al. Among authors: burkhardt o. Crit Care. 2015 Mar 6;19(1):74. doi: 10.1186/s13054-015-0792-1. Crit Care. 2015. PMID: 25887979 Free PMC article.

7

Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.

Burkhardt O, Derendorf H, Welte T. Burkhardt O, et al. Expert Opin Pharmacother. 2007 Feb;8(2):237-56. doi: 10.1517/14656566.8.2.237. Expert Opin Pharmacother. 2007. PMID: 17257093 Review.

8

[Modern artificial respiration concepts in the treatment of acute respiratory distress syndrome].

Ellis S, Burkhardt O, Welte T. Ellis S, et al. Among authors: burkhardt o. Dtsch Med Wochenschr. 2008 Nov;133(48):2522-6. doi: 10.1055/s-0028-1100951. Epub 2008 Nov 19. Dtsch Med Wochenschr. 2008. PMID: 19021086 Review. German.

9

Predicting outcome and survival in patients with Wegener's granulomatosis treated on the intensive care unit.

Burkhardt O, Köhnlein T, Wrenger E, Lux A, Neumann KH, Welte T. Burkhardt O, et al. Scand J Rheumatol. 2007 Mar-Apr;36(2):119-24. doi: 10.1080/03009740600958611. Scand J Rheumatol. 2007. PMID: 17476618

10

Linezolid - the first oxazolidinone in the treatment of nosocomial MRSA pneumonia.

Burkhardt O, Pletz MW, Mertgen CP, Welte T. Burkhardt O, et al. Recent Pat Antiinfect Drug Discov. 2007 Jun;2(2):123-30. doi: 10.2174/157489107780832659. Recent Pat Antiinfect Drug Discov. 2007. PMID: 18221168 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

80 results

Search Page

Filters